Presentations – Pharmaceutics and Medical Devices

Cronin-Fenton D, Dalvi T, Fryzek J, Hansen H, Hamilton-Dutoit S, Hedgeman E, Mellemgaard A, Norgaard M, Pedersen L, Potter D, Rasmussen TR, Rigas J, Shire N, Sorensen HT, Walker J. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the International Society for Pharmacoepidemiology Annual Conference, August 22-26, 2018, Prague, Czech Republic.

Bylsma LC, Gulbech Ording A, Froslev T, Mehnert F, Fryzek JP, Morales Arias J, Roth A, Sorensen HT, Berentsen S. Occurrence, survival, and thromboembolic risk in cold agglutinin disease: a population-based cohort analysis. Presented at the 23rd Congress of the European Hematology Association, June 14-17 2018, Stockholm, Sweden.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the American Association for Cancer Research (AACR) Annual Meeting 2018, April 14-18, 2018, Chicago, IL.

Bylsma LC, Gillezeau C, Garawin T, Kelsh M, Fryzek J, Sangare L, Lowe KA. Prevalence of RAS and BRAF Mutations in Metastatic Colorectal Cancer (mCRC) Patients by Tumor Location. Presented at the Gastrointestinal Cancers Symposium, January 18-20, 2018, San Francisco, CA.

Broome C, Cunningham JM, Mullins M, Jiang X, Bylsma L, Fryzek J, Rosenthal A. Incidence of Thromboembolic Events Is Increased in a Retrospective Analysis of a Large Cold Agglutinin Disease (CAD) Cohort. Presented at the American Society of Hematology, December 9-12, 2017, Atlanta, GA.

Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston SA, Okerson T. Monitoring Frequency After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association Scientific Sessions, November 11-15, 2017, Anaheim, CA.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Lawrence D, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mutations in First-Line Therapy (1L) for non-small cell lung cancer (NSCLC) patients. Presented at the 18th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) 2017, October 15-18, 2017, Yokohama, Japan.

Ruzin A, Levin-Sparenberg E, Pastula S, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Yu L, Hackett J, Villafana T, Esser MT. Characterization of RSV Strains Among U.S. Patients in the OUTSMART RSV Program During 2015-16. Presented at ID Week 2017, October 4-6, 2017, San Diego, CA.

Okerson T, Cohen SS, Killian JM, Weston SA, Monda KL, Chamberlain AM. Changes in Lipid-Lowering Therapy Following a Cardiovascular Event in Patients with Diabetes Mellitus. Presented at the 53rd Annual Meeting of the European Assocation for the Study of Diabetes, September 11-15, 2017, Lisbon, Portugal.

Soff GA, Ray-Coquard I, Marfil Rivera LJ, Fryzek J, Mullins M, Bylsma LC, Park JK. Literature Review of Thrombopoietin Receptor Agonists (TPO-RA) for Chemotherapy-Induced Thrombocytopenia (CIT). Presented at the European Society for Medical Oncology 2017 Congress, September 8-12, 2017, Madrid, Spain.

Chamberlain AM, Cohen SS, Killian JM, Weston SA, Okerson T, Monda KL. Changes in Lipid-Lowering Therapy Prescription Patterns following a Second Cardiovascular Disease Event. Presented at the European Society of Cardiology Congress 2017, August 26-30, 2017, Barcelona, Spain.

Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston SA, Okerson T. Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Atherosclerotic Cardiovascular Disease. Presented at the American Diabetes Association’s 77th Scientific Sessions, June 9-13, 2017, San Diego, CA.

Ruterbusch JJ, Bylsma LC, Fryzek J, Barlev A, et al. Bicalutamide Treatment Patterns in Elderly Prostate Cancer Patients: A Historical Cohort Study Using the Surveillance, Epidemiology and End Results Program (SEER)-Medicare Database. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, May 20-24, 2017, Boston, MA.

Fryzek JP, Ruterbusch JJ, Garabrant DH, Dalvi T, Beebe-Dimmer JL. Healthcare Resource Utilization and Costs of Care for Mesothelioma Medicare Beneficiaries. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting, May 20-24, 2017, Boston, MA.

Chamberlain AM, Cohen SS, Killian JM, Monda KL, Hedgeman E, Weston SA, Okerson T. Lipid-lowering Therapy Prescription Patterns and Predictors of High Intensity Statin Prescriptions in Patients With Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association’s Epidemiology and Prevention – Lifestyle 2017 Scientific Sessions, March 7, 2017, Portland, OR.

Chamberlain AM, Cohen SS, Killian JM, Beaubrun AC, Monda KL, Hedgeman E, Weston SA, Okerson T. Lipid-Lowering Therapy Prescriptions Immediately Before and After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association Scientific Sessions, November 1, 2016, New Orleans, LA.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of Respiratory Syncytial Virus Disease among Adults in the United States from 1997 to 2012. Presented at ID Week 2016, October 26-30, 2016, New Orleans, LA.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Mortensen K, Midta A, Shire N, Brody R, Fryzek J, Lawrence D, Rigas J, Potter D, Walker J, Mellemgaard A, Rasmussen TR, Hamilton-Dutoit S, Sorensen HT. An interim assessment of key biomarkers (programmed cell death receptor ligand 1 (PD-L1) expression and epidermal growth factor receptor (EGFR) in third-line therapy non-small cell lung cancer (NSCLC) patients: A Danish cohort study. Presented at the 41st European Society for Medical Oncology (ESMO) Congress, October 7-11 2016, Copenhagen, Denmark.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of respiratory syncytial virus disease among adults in the United States from 1997 to 2012. Presented at the International Society for Influenza and Other Respiratory Virus Diseases (ISIRV) 2016 – Options IX For the Control of Influenza, August 24-28, 2016, Chicago, IL.

Cetin K, Callaghan F, Fryzek J, Bylsma L, Bezold C, Mehta B. Safety and Efficacy/Effectiveness of 2nd-line Treatments in Immune Thrombocytopenia (ITP): A Systematic Review of the Literature. Presented at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 25-28, 2016, Dublin, Ireland.

Cetin K, Callaghan F, Fryzek J, Bylsma L, Bezold C, Mehta B. Safety and Efficacy/Effectiveness of Second-line Treatments in Patients with Immune Thrombocytopenia: A Systematic Review of the Literature. Presented at the 21st Congress of the European Hematology Association, June 9 – 12, 2016, Copenhagen, Denmark.

Fryzek J, Alexander DD, Summers N, Fraysse J, Reichert H, Townes L, Vanderpuye-Orgle J. Indirect treatment comparison of cabazitaxel for patients with metastatic castration-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen. Presented at the 21st Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 21-25, 2016, Washington, DC.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of Respiratory Syncytial Virus Disease Among Adults in the United States from 1997 to 2012. Presented at the 21st Annual International Society for Pharacoeconomics and Outcomes Research, May 21-25, 2016, Washington, DC.

Meddings J, Kuhn L, Reichert H. Indwelling Urinary Catheter Awareness, Order, and Indications in ICUs. Presented at the Society for Healthcare Epidemiology of America (SHEA) Annual Meeting, May 18-21, 2016, Atlanta, GA.

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the Society of General Internal Medicine (SGIM) 2016 Annual Meeting, May 11-14, 2016, Hollywood, FL.

Cetin K, Callaghan F, Fryzek JP, Bylsma LC, Bezold C, Mehta B. Safety and Efficacy/Effectiveness of Second-line Treatments in Patients with Immune Thrombocytopenia: A Systematic Review of the Literature. Presented at the Thrombosis & Hemostasis Summit of North America 2016, April 14-16, 2016, Chicago, IL.

Bylsma LC. Safety and Efficacy/Effectiveness of Second-line Treatments in Patients with Immune Thrombocytopenia: A Systematic Review of the Literature. Presented at the 3rd Biennial Summit of the Thrombosis & Hemostasis Societies of North America, April 14-16, 2016, Chicago, IL.

Cohen SS, Shirey-Rice J, Hardin J, Monda K, Fryzek JP, Fazio S, Denny JC, Wei WQ, Lipworth LL. Identification of patients with familial hypercholesterolemia (FH) using the Dutch Lipid Network (DLN) criteria in Electronic Health Records (EHR). Presented at the American Heart Association EPI Lifestyle Scientific Sessions, March 1-4, 2016, Phoenix, AZ.

Cohen SS, Kabagambe EK, Shirey-Rice J, Hardin J, Monda K, Fryzek JP, Fazio S, Denny JC, Wei WQ, Lipworth LL. Achievement of LDL-cholesterol reduction targets is associated with reduced cardiovascular disease risk among patients with familial hypercholesterolemia in a large electronic medical record database. Presented at the American Heart Association 2015 Scientific Sessions, November 7-11, 2015, Orlando, FL.

Fryzek J, Doucette A, Jiang X, Coalson J, McLaurin K, Ambrose CS. Trends in Respiratory Syncytial Virus and Bronchiolitis Infant Hospitalization Rates in High-Risk Infants in a US Nationally Representative Database (1997–2012). Presented at ID Week, October 7-11 2015, San Diego, CA.

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the 2015 Agency for Heathcare Research and Quality (AHRQ) Research Conference, October 4-6, 2015, Crystal City, VA.

Lipworth LL, Shirey-Rice J, Wei WQ, Hardin J, Shi G, Monda K, Fryzek JP, Fazio S, Cohen SS, Denny JC. Identification and characterization of heterozygous familial hypercholesterolemia patients using the Vanderbilt University Medical Center Synthetic Derivative database. Presented at the European Society for Cardiology Congress, August 29 – September 1, 2015, London, United Kingdom.

Doucette A, Hedgeman E, Fryzek J. Assessing the Agreement of Hospitalization Estimates Between Three Nationally Representative US Hospital Discharge Databases, the Nationwide Inpatient Sample (NIS), the National Hospital Discharge Survey (NHDS) and the Kid’s Inpatient Database (KID). Presented at the International Conference of Pharmacoepidemiology, August 24-26 2015, Boston, MA.

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Academy Health Annual Research Meeting, June 14-15, 2015, Minneapolis, MN.

Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. Comparison of trends in bronchiolitis and respiratory syncytial virus infant hospitalizations rates in 3 US nationally representative databases. Presented at the Pediatric Academic Societies Annual Meeting, April 25-28 2015, San Diego, CA.

Liu B, Karath SM, Sekeres MA, Fryzek JP, Mutetwa BT, Sreekantaiah C, Mason C, Kolitz, Taioli E. Insights into the spatial clustering and disease etiology of myelodysplastic syndromes. Presented at the New York City Epidemiology Forum, February 27, 2015, New York City, NY.

Alexander DD. Overview of FDA Health Claims and the Submission Process. Presented as a webinar, January 13, 2015, Webinar.

Kerath SM, Sekeres MA, Fryzek JP, Mutetwa BT, Sreekantaiah C, Mason CR, Kolitz J, Taioli E. Clinical characteristics and outcomes in a large sample of MDS patients. Presented at the American Public Health Association (APHA) Annual Meeting and Exposition, November 15-19 2014, New Orleans, LA.

Meddings J, Saint S, Krein S, Gaies E, Reichert H, Hickner A, McNamara S, Mody L. Systematic review of interventions to reduce catheter-associated urinary tract infection in the long-term care setting. Presented at ID Week, October 10, 2014, Philadelphia, PA.

Reichert H, McMahon LF, Meddings J. Did hospital-acquired pressure ulcer rates decrease after implementation of non-payment as a comorbidity with the 2008 Hospital-Acquired Conditions Initiative? Presented at the Academy Health Annual Research Meeting, June 8-10, 2014, San Diego, CA.

Reichert H, McMahon LF, Meddings J. Risk-adjusting hospital-acquired pressure ulcer rates from administrative data: how do hospitals perform by the risk-adjusted AHRQ Patient Safety Indicator 3 compared to a proposed measure using risk-standardization applied by the Centers for Medicare and Medicaid Services for other outcomes? Presented at the Academy Health Annual Research Meeting, June 8-10, 2014, San Diego, CA.

Reichert H, Welch K. Conceptualizing Statistics: A Heuristic Approach. Presented at the University of Michigan’s Division of General Medicine Spring Retreat, May 1, 2014, Ann Arbor, MI.

Budelmann C, Reichert H, Meddings J. Are you ex-Foley-ating? A hospital-wide intervention to decrease urinary catheter use, including nurse-directed positive-reinforcement strategies. Presented at the Society of General Internal Medicine Annual Meeting, April 23-26, 2014, San Diego, CA.

Reichert H, McMahon LF, Meddings J. Hospital-acquired catheter-associated urinary tract infections: reported by mandate to the National Healthcare Safety Network, but rarely listed as diagnoses in claims data. Presented at the Society of General Internal Medicine Annual Meeting, April 23-26, 2014, San Diego, CA.

Hedgeman E, Lipworth L, Lowe K, Saran R, Do T, Fryzek J. International burden of chronic kidney disease: review of the literature and online data systems. National Kidney Foundation Spring Clinical Meeting, April 22-26, 2014, Las Vegas, NV.

Reichert H, Welch K. Conceptualizing Statistics: A Heuristic Approach. Presented at the 2014 American Statistical Association (ASA) Conference on Statistical Practice, February 20-22, 2014, Tampa, FL.

Reichert H, Meddings J. What’s so Standard About Risk Standardization? Presented at the 2014 American Statistical Association (ASA) Conference on Statistical Practice, February 20-22, 2014, Tampa, FL.

Reichert, H. Qualtrics (and other survey tools): Beyond Opinion Surveys. Presented at the University of Michigan Institute for Healthcare Policty and Innovation (IHPI) Methods Seminar, February 1, 2014, Ann Arbor, MI.

Metha J, Le-Ruet O, Fryzek J, Iqbal U, Olivares R, Mesa R. Epidemiology of primary myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Presented at the European Cancer Congress (ESMO), September 27-October 1, 2013, Amsterdam, Netherlands.

Meddings J, Reichert H, Grazier KL, Rogers MAM, Hofer T, McMahon LF. Effect of Payment Changes for Pressure Ulcers from the Hospital-Acquired Conditions Initiative: A Statewide Analysis. Presented at the 2013 AcademyHealth Annual Research Meeting, June 23-25, 2013, Baltimore, MD.

Meddings J, Reichert H, Rogers MAM, Hofer T, McMahon LF. Risk-adjusting Hospital-acquired Pressure Ulcer Rates from Claims Data: Teaching Hospitals Beware. Presented at the 2013 AcademyHealth Annual Research Meeting, June 23-25, 2013, Baltimore, MD.

Bylsma LC. Parental Trust in Health Information Sources and Influenza Vaccination in Children. Presented at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference, June 9-13, 2013, Pasadena, CA.

Reichert, H. Risk Standardization. Presented at the Institute for Healthcare Policy and Innovation (IHPI) Methods Seminar, June 1, 2013, Ann Arbor, MI.

Meddings J, Reichert H, Rogers MAM, Hofer T, McMahon LF. Risk-adjusting Hospital-acquired Pressure Ulcer Rates from Claims Data: Teaching Hospitals Beware. Presented at the 2013 Society of General Internal Medicine Annual Meeting, April 24-27, 2013, Denver, CO.

Meddings J, Reichert H, Grazier KL, Rogers MAM, Hofer T, McMahon LF. Effect of Payment Changes for Pressure Ulcers from the Hospital-Acquired Conditions Initiative: A Statewide Analysis. Presented at the 2013 Society of General Internal Medicine Annual Meeting, April 24-27, 2013, Denver, CO.

Li J, Dalvi T, Pawaskar M, Tsai K, Caspard H, Fryzek J. Recent trends in the characteristics of patients with distant stage breast cancer in the United States Surveillance, Epidemiology and End Stage Disease program. Presented at the 2012 CTRC−AACR San Antonio Breast Cancer Symposium, December 4-8, 2012, San Antonio, TX.

Nielsen Nguyen M, Pedersen, Olesen Braae A, Wang L, Hou J, Mackey H, McCusker M, Basset-Seguin N, Fryzek J. The incidence of metastatic basal cell carcinoma in Denmark, 1997-2010. Presented at the 6th World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers in conjunction with the 8th EADO Congress, November 14-17 2012, Barcelona, Spain.

Nielsen Nguyen M, Skovbo S, Svaneby D, Pedersen L, Fryzek JP. The prevalence of X-linked hypohidrotic ectodermal dysplasia in Denmark, 1995-2010. Presented at the American Society of Human Genetics Annual Meeting, November 6-10, 2012, San Francisco, CA.

Nordyke RJ, Zolfaghari S. Estimating the value of companion diagnostics: Getting the incentives Right. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual European Meeting, November 3-6, 2012, Berlin, Germany.

Meddings J, Reichert H, Saint S, McMahon LF. Why are hospital rates of catheter-associated UTIs so low in claims data? Presented at the 2012 Society for Healthcare Epidemiology of America / ID Week, October 17-21, 2012, San Diego, CA.

Yoon D, Fryzek JP, Doemland ML, Kim SM. Prescription pattern dispensed from pharmacies in South Korea, using national health insurance data. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Kuehn C, Watson H, Ong K, Mohamed M, Ochoa JA, Fryzek J. Descriptive Epidemiology of Medical Device Use among Patients with Breast, Lung or Prostate Cancer in the National Inpatient Sample. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Skovbo S, Nguyen-Nielsen, Pedersen, Sørensen HT, Fryzek J. The Prevalence of X-linked Hypohidrotic Ectodermal Dysplasia in Denmark from 1995-2010. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu Xiao, Lash TL, Sørensen HT, Fryzek JP. Healthcare resource utilization associated with hospitalization for acute exacerbation of chronic obstructive pulmonary disease and subsequent post-hospitalization recurrence and death a: a Danish cohort study. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Meddings J, Reichert H, Rogers MAM, Hofer TP, McMahon L. Adjusting for patients’ clinical risk of urinary tract infections: a necessary step in pay-for-performance when comparing by hospital-acquired complication rates. Presented at the 2012 AcademyHealth Annual Meeting, June 24-26, 2012, Orlando, FL.

Meddings J, Reichert H, McMahon L. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Presented at the 2012 AcademyHealth Annual Meeting, June 24-26, 2012, Orlando, FL.

Meddings J, Reichert H, Rogers MAM, Iwashyna TJ, McMahon L. Hospitals reporting better adherence to perioperative blood clot prophylaxis do not report lower rates of hospital-acquired post-operative blood clots. Presented at the 2012 AcademyHealth Annual Meeting, June 24-26, 2012, Orlando, FL.

Fordyce T, Mowat F, Fryzek J, Lau E. Incidence of metastatic hormone receptor positive (HR+) breast cancer in the United Kingdom: Data Needed. Presented at the 17th Annual International Society for Pharacoeconomics and Outcomes Research, June 2-6, 2012, Washington, DC.

Nordyke RJ, Nathan S, Corey-Lisle T. Using Early-Stage Economic Models to Integrate Clinical and Commercial Development. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual International Meeting, June 2-6, 2012, Washington, DC.

Meddings J, Reichert H, Rogers MAM, Iwashyna TJ, McMahon L. Hospitals reporting better adherence to perioperative blood clot prophylaxis do not report lower rates of hospital-acquired post-operative blood clots. Presented at the 2012 Society of General Internal Medicine Annual Meeting, May 9-12, 2012, Orlando, FL.

Meddings J, Reichert H, McMahon L. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Presented at the 2012 Society of General Internal Medicine Annual Meeting, May 9-12, 2012, Orlando, FL.

Meddings J, Reichert H, Rogers MAM, Hofer TP, McMahon L. Adjusting for patients’ clinical risk of urinary tract infections: a necessary step in pay-for-performance when comparing by hospital-acquired complication rates. Presented at the 2012 Society of General Internal Medicine Annual Meeting, May 9-12, 2012, Orlando, FL.

Alexander DD, Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX.

Yong M, Christiansen CF, Gammelager H, Sværke C, Chia V, Atchison C, Fryzek J. Healthcare resource utilization among breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1997 – 2009). Presented at the 34th Annual San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX.

Nordyke RJ, Imbeah-Ampiah R, Ng-Haing J, Oshinowo B, Saraf S. Does a lack of HTA review lead to higher prices for HIV treatments? A comparison with oncology treatments. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual International Meeting, May 21-25, 2011, Baltimore, MD.

Dean BB, Aguilar D, Whyte J, Nordyke RJ . Patient privacy and data confidentiality and the use of secondary data. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual International Meeting, May 16-20, 2009, Orlando, FL.

Mitchell J, Mehta J, Lau E, Fryzek J. National-level descriptive epidemiology of pediatric acute lymphoblastic leukemia. Presented at the 24th Annual Meeting of the American Society of Pediatric Hematology/Oncology, April 13-16, 2011, Baltimore, MD.

Fryzek JP, Makari D, Martone WJ, Groothuis JR. Trends in Inpatient RSV Hospitalization in Young Children: An 8-Year Cohort Study using the US National Hospital Discharge Survey. Presented at the 3rd Congress of the European Academy of Paediatric Societies, October 23-26, 2010, Copenhagen, Denmark.

Groothuis JR, Fryzek JP, Makari D, Martone WJ. Respiratory Syncytial Virus Hospitalization (RSVH) in infants with Chronic Lung Disease: An 8 year Retrospective National Hospital Survey. Presented at the 3rd Congress of the European Academy of Paediatric Societies, October 23-26, 2010, Copenhagen, Denmark.

Beebe-Dimmer J, Schwartz KA, Cetin K, Morgenstern H, Yee C, Bartoces M, Shahinian V, Fryzek J, Acquavella J. Incidence of cataract among elderly prostate cancer patients receiving androgen deprivation therapy in the United States using the Surveillance, Epidemiology, and End Results-Medicare database. Presented at the American Society of Clinical Oncology (ASCO) Annual Conference, June 9-11, 2010, Chicago, IL.

Groothuis JR, Fryzek JP, Makari D, Martone WJ. Respiratory Syncytial Virus Hospitalization (RSVH) in infants with Chronic Lung Disease: An 8 year Retrospective National Hospital Survey. Presented at the 2010 Pediatric Academic Societies’ Annual Meeting, May 1-4, 2010, Vancouver, BC, Canada.